Oncology Nursing Symptom Science: Overview of the NINR, ONS, and NCI Symptom Science Colloquium.

ONCOLOGY nursing; NATIONAL Institute of Nursing Research (U.S.); ONCOLOGY Nursing Society; TEACHER-student relationships; TERMINAL care; COVID-19; HEALTH services accessibility; COLLEGE teachers; HEALTH status indicators; PHILOSOPHY of nursing; UNDERGRADUATES; CANCER patients; NURSING research; INTERPROFESSIONAL relations; NURSES; MASTERS programs (Higher education); SCALE analysis (Psychology); DESCRIPTIVE statistics; NATIONAL Cancer Institute (U.S.); NURSE practitioners; THEMATIC analysis; PALLIATIVE treatment

This article provides an overview of the process, development, and evaluation of the Symptom Science Colloquium sponsored by the National Institute of Nursing Research, Oncology Nursing Society (ONS), and National Cancer Institute. This colloquium was the first of its kind to leverage the common goals of these institutes to advance oncology symptom science. Specifically, this article will identify the goals of the agencies involved and synergy in forming this collaboration, review the ONS Research Agenda that provided the blueprint for the colloquium, and offer insights and lessons learned to be used for future planning. The colloquium engaged roughly 500 participants from all levels of clinical (RNs, advanced practice nurses), educational (undergraduate, master's, doctorate), and research (students, faculty, scientists) expertise. Six featured expert speakers and 115 poster presentations focused on the latest research in symptom science, cancer survivorship, palliative and end-of-life care, and hot topics (COVID-19, health disparities). Fourteen networking sessions fostered opportunities to engage with international experts. Special awards emphasized mentee-mentor relationships and exemplary midcareer faculty. Based on this emphasis, the authors provide themes from the successful award applications as exemplars. A summary of participant satisfaction and recommendations for future collaborations to enhance and advance oncology symptom science are provided. [ABSTRACT FROM AUTHOR]